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Candidate evaluation
The primary goal of evaluating patients for liver transplantation (LT) is 
to identify appropriate candidates and establish a pre-transplantation 
plan. Prospective patients must first be referred to a transplantation 
centre for evaluation and, if deemed suitable, for work-up, with a 
view to being listed for transplantation. South Africa has centres 
offering LT in Johannesburg and Cape Town. Typically, referred 
patients are evaluated by a clinician, and further evaluations and tests 
are performed before the patient is discussed at a multidisciplinary 
transplantation meeting. Initiating the referral early in the course of 
disease facilitates improved outcomes, by allowing earlier LT before 
the establishment of end-stage disease. It is also well described that 
patients awaiting transplantation (and their families) demonstrate 
better psychological adaptation when the entire spectrum of issues is 
approached by a multidisciplinary clinical team.1 It is not uncommon 
for children to exhibit behavioural problems, depression, poor social 
adaptation and non-compliance after transplantation, which can be 
moderated by early counselling after referral.2 
Purpose and policy
Organ availability is the rate-limiting step regarding successful 
transplantation and a reduction in waiting-list mortality. This is 
particularly applicable in centres that do not have related living donor 
programmes, but rely solely on deceased donor organs. Consequently, 
the decision-making and selection process must be transparent, and a 
consistent set of evidence-based criteria must be applied to determine 
whether selection for transplantation is appropriate.
Indications 
Borne out by our experience, approximately 50% of paediatric 
patients requiring LT have biliary atresia.2 However, the indications 
for LT fall into 5 major categories of liver disease: (i) cholestatic 
diseases; (ii) metabolic disorders; (iii) fulminant liver failure; (iv) 
auto-immune hepatitis; and (v) liver tumours.
General listing criteria
Infants and children should be listed for LT when there is evidence 
that hepatic decompensation has occurred, is imminent, or is 
inevitable based on the natural history of the disease. Clinical end-
points that determine suitability for transplantation may include 
one or more of the following: severe cholestasis; portal hypertension 
with/without variceal bleeding; multiple episodes of ascending 
cholangitis; failure of hepatic synthetic function; malnutrition and 
failure to thrive; intractable ascites; encephalopathy; unacceptably 
poor quality of life due to liver disease; and life-threatening 
complications of stable liver disease, such as hepatopulmonary 
syndrome.
Pre-LT assessment and work-up
The first step in evaluating a potential candidate for LT is to determine 
the severity and prognosis of the liver disease. A subjective clinical 
assessment is undertaken together with an objective assessment 
including comprehensive laboratory and radiological evaluations. 
The aim of this is to: (i) identify contra-indications that would either 
exclude LT, require discussion on a case-by-case basis or could 
be optimised; (ii) identify comorbidities or psychosocial factors 
that reduce the expectation of successful LT; and (iii) determine 
the wishes of the patient and family regarding LT.1,3 This in-depth 
assessment determines the suitability of the patient for potential 
listing, allowing better allocation of resources and, ideally, optimising 
the survival rate of LT recipients. 
Current contra-indications in children include: non-resectable 
extrahepatic malignancy; concomitant end-stage organ failure that 
cannot be corrected by combined transplantation; uncontrolled 
sepsis; and irreversible serious neurological damage.
Once transplantation is considered, a specially trained 
multidisciplinary clinical team meets with the patient and family 
to assess suitability for LT and to provide further counselling. 
The team usually includes: a hepatologist; a transplant surgeon; a 
cardiologist; a pulmonologist; an anaesthesiologist; transplantation 
co-ordinators and nursing staff; a psychiatrist and/or psychologist;  a 
physiotherapist; a dietician; and a social worker.
The general work-up is as follows, although specific additional 
testing may be performed on a case-by-case basis:
• Biochemistry
• Full blood count and grouping
• Qualitative liver function tests, including synthetic function 
(albumin and international normalised ratio (INR))
• Urea and electrolytes, with urine microscopy, culture and 
sensitivities 
• Alpha-fetoprotein
• Vitamins A, E and D
The evaluation of the liver transplantation candidate is intended to 
confirm the indication for transplantation, determine the severity 
of disease, exclude contra-indications, optimise pre-transplantation 
care and candidate condition, and educate the patient and family 
on post-procedure expectations. This article is intended as a guide 
for the appropriate selection and work-up of patients for liver 
transplantation.
S Afr Med J 2012;102(11):876-878. DOI:10.7196/SAMJ.6146
Michele Zuckermann and Jerome Loveland, hepatologist and surgeon 
respectively, both work in the Department of Paediatric Surgery, Chris Hani 
Baragwanath Academic Hospital, and Transplant Division, Wits Donald 
Gordon Medical Centre, both affiliated to the University of the Witwatersrand, 
Johannesburg, South Africa. 
Corresponding author: J A Loveland (loveland@wol.co.za)
FORUM
877  November 2012, Vol. 102, No. 11  SAMJ
• Serology: hepatitis A, B, C, varicella, HIV, cytomegalovirus, 
Epstein-Barr virus, herpes simplex virus (HSV) and measles.
• Radiology 
• Chest X-ray – abdominal ultrasound (Duplex Doppler), 
looking specifically at: patency of portal vein with direction 
of flow; presence of ascites; vascular anatomy of coeliac axis, 
including hepatic artery resistance index; splenic size; and 
additional indicators of portal hypertension
• Magnetic resonance angiography, or angiography if vascular 
anatomy is uncertain (to be discussed with the surgeons).
• Cardiology
• Electrocardiogram and echocardiogram.
• Respiratory 
• Cough swab or tracheal aspirate for acid-fast bacilli and 
culture
• Oxygen saturations
• Respiratory function tests in selected patients.
• Anthropometry 
• Immunisation record
• Dental review
• Assessment of the severity of liver disease
• Upper gastro-intestinal endoscopy (if there is evidence of 
variceal bleeding)
• Liver biopsy to assess hepatic architecture
• Calculation of paediatric hepatology score (Paediatric End-
Stage Liver Disease (PELD) score – see below).
Listing of candidates
On completion of the work-up, the patient and results are considered by 
the candidate’s selection committee for a decision regarding suitability 
for LT. This committee consists of the listed multidisciplinary team 
and may include the patient’s primary care physician. While the 
structure of this committee may vary substantially between centres,4 
the process is uniform and primarily involves inductive reasoning to 
review suitability for LT and possible reasons for exclusion. The latter 
include systemic comorbidities, patients being ‘not sick enough’ or 
‘too sick’, and other psychosocial barriers. There is scant information 
on the quality of life of paediatric LT recipients and their families. 
Results suggest that psychological support should be made available 
to both, before and after the operation. Particular attention should 
be paid to the partners of related living donors and the siblings 
of affected children to minimise secondary phenomena including 
marital difficulties, sibling neglect, and other psychological problems 
before and after LT.
The following questions are posed to the committee before listing 
a patient for LT: 
• Does the patient need LT as therapy for disease?
• Have the indications and contra-indications been assessed 
properly?
• What is the surgical risk?
• Is the patient’s medical condition such to allow tolerance of the 
procedure and post-operative course?
• What are the chances of recurrent disease affecting graft and 
patient survival?
Prioritisation
The allocation criteria for a resource as scarce as a donor liver became 
crucial in 1999 when it was shown that waiting time – a previous 
listing criterion – constituted a poor predictor of pre-transplant 
mortality. An allocation score centred on objective parameters and 
based on continuous scale measuring of the severity of end-stage liver 
disease was required.5
The liver allocation system, implemented by the Organ 
Procurement Transplantation Network in the USA in 2002, is 
based primarily on the severity of liver disease, assessed by 
the Model for End-stage Liver Disease (MELD) for adults and 
PELD for paediatric patients with chronic liver disease.6,7 The 
system employs risk determination based on a 3-month pre-
transplantation assessment, and quantifies the risk of death within 
the 3 months post transplantation (the higher the score, the higher 
the mortality). The PELD model, based on analyses of data from the 
Studies of Pediatric Liver Transplantation (SPLIT), has been shown 
retrospectively to be predictive of waiting list mortality in paediatric 
patients. The PELD score, derived from bilirubin, albumin, INR, 
growth failure and patient age when first placed on the waiting list, 
may be calculated with a tool available on the United Network for 
Organ Sharing (UNOS) website.8 
This system is a step towards a more precise and accountable means 
of ranking patients and may contribute to reduced waiting times and 
pre-transplantation mortality among children with advanced liver 
disease – rather than allocating organs to patients who have waited 
longer but are more stable. The PELD score has not been proven to be 
a successful predictor of post-transplantation outcome, but has also 
not been shown to adversely affect results.7,9,10
Waiting period and pre-transplantation 
care
Optimising the clinical status of the child on the waiting list is 
essential, particularly as waiting times are becoming longer and, 
unfortunately, there are many more potential recipients than donors. 
Aggressive medical management is often required to treat the major 
complications of liver failure: intractable ascites; variceal bleeding; 
and hepatorenal syndrome. The management of malnutrition is 
the most important contribution of paediatric hepatologists and 
dieticians to patient management. Nutrition is one of few variables, 
known to affect both pre- and post-transplantation outcome, that 
can be prevented or ameliorated. Better-nourished children have 
decreased mortality, a lower infection risk and fewer post-operative 
surgical complications.11-13
Particular attention is also paid to immunisation. If feasible, live 
vaccines are administered before transplantation (varicella with 
measles, mumps and rubella, if aged >6 months) and caregivers are 
given advice on completing other vaccines, such as pneumococcal 
and hepatitis A and B. Candidates are suspended from the 
transplantation waiting list for 2 weeks following vaccination with 
live virus vaccines. 
Outcome and graft survival following LT
The overall results of paediatric LT are encouraging. UNOS reported 
on 9 064 children transplanted between 1997 and 2004, with 1-year 
patient and graft survival rates of 86% and 78% among children aged 
1 - 5 years.14,15 The SPLIT registry report on 1 611 patients showed 
1-year patient and graft survival rates of 88% and 82%, respectively.16 
Age at diagnosis, severity of illness, and possibly the technical 
variants of grafts utilised (reduced-size and split grafts), may be 
associated with increased morbidity and decreased overall survival.17 
Ng et al. reported second and third transplantation rates of 12% 
and 2%, respectively, 5% chronic rejection, and 6% post-transplant 
lymphoproliferative disease in their paediatric LT cohort.18 Although 
tests of graft function were preserved in 90% of 5-year survivors in 
the cohort, one-third of children did not have complete normalisation 
of liver enzymes, suggesting ongoing graft inflammation.18
Most long-term survivors of paediatric LT retain good graft 
function, but may have chronic medical conditions and post-
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transplantation complications. LT success is determined by more 
than graft survival rates; ongoing management requires the 
involvement and commitment of healthcare providers within and 
beyond transplantation teams.
Living donor liver transplantation
Introduced in 1989, living donor liver transplantation (LDLT) has 
developed as an alternative to deceased donor transplantation, to 
overcome the critical organ shortage, particularly in Asia. Living 
donor transplantation in children is common practice worldwide, 
and achieves results comparable with those performed with deceased 
donor organs.19 Biliary atresia is an indication for LDLT, and 
caregivers frequently question the possibility of using this approach 
early in the course of LT work-up.
LDLT raises several ethical and technical considerations for the 
donor and recipient; the balance between recipient benefit and the 
risk of donor morbidity and mortality is central to its justification. 
Donor safety is of utmost concern. The primary donor selection 
criterion remains voluntary and informed consent, followed by 
extensive counselling, work-up and evaluation of donor suitability. 
Internationally reported donor morbidity rates range from 0% to 
67%, depending on the individual definition and recognition of 
morbidity, which undoubtedly correlates with the experience and 
volumes of individual centres.20 The donor mortality rate has been 
estimated to be between 0.1% and 0.3%.
Graft and recipient size matching are important to achieve 
successful outcomes. The metabolic demands of the recipient must 
be met, providing a sufficient graft size to meet the recipient’s needs 
without compromising the donor’s safety. The refinement of surgical 
technique, together with a greater understanding of the anatomical 
and physiological differences in LDLT when compared with deceased 
donor LT, has improved outcome.
The proven or potential benefits of LDLT include: a reduction in 
waiting time (thereby decreasing waiting list mortality); the selection 
of appropriate timing for transplantation; the superior quality of 
the donor liver; and significant expansion of the donor pool. Before 
the addition of a living donor programme to a transplantation unit, 
the risk-to-benefit ratio, availability of deceased donor organs, 
infrastructure, and recipient demands must be considered.
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